Effect of rapamycin on rat aortic ring vasomotion

Area of Science:

• Pharmacology
• Vascular Biology
• Immunology

Background:

• Rapamycin (RAPA) is known for its antifungal and immunosuppressive properties.
• Emerging research suggests potential roles beyond its primary applications.
• Understanding RAPA's vascular effects is crucial for exploring new therapeutic avenues.

Purpose of the Study:

• To investigate the in vitro effects of Rapamycin (RAPA) on isolated rat aortic ring tension.
• To determine if RAPA exhibits vasodilatory or vasoconstrictive properties.
• To elucidate the mechanism of RAPA's vascular action, particularly its dependence on the endothelium.

Main Methods:

• Isolated rat aortic rings (intact and denuded) were used in organ chambers.
• Rings were treated with Rapamycin (RAPA) or its polysorbate/polyethylene glycol (PEG) vehicle.
• Vascular tension was measured after stimulation with KCl, thromboxane A2 analogue (U46619), and phenylephrine (PE).

Main Results:

• The PEG vehicle potentiated basal tension in intact rings.
• Rapamycin (RAPA) dose-dependently antagonized vehicle-induced contraction.
• At high concentrations, RAPA induced significant relaxation in intact rings, an effect absent in denuded rings, indicating an endothelium-dependent mechanism.

Conclusions:

• Rapamycin (RAPA) exerts an endothelium-dependent vasodilatory effect on rat aortic rings.
• The polysorbate/polyethylene glycol (PEG) vehicle used for RAPA administration can influence vascular tone.
• These findings suggest novel vascular properties of Rapamycin (RAPA) that warrant further investigation.